Skip to main content

Events

Solstice Oncology Launches with $225M Series A for CTLA-4 Antibody

Image
Solstice Oncology Launches with $225M Series A for CTLA-4 Antibody

Cambridge, Mass. – September 13, 2026 -- Solstice Oncology has launched with a $225 million Series A financing led by RA Capital Management, with participation from Canaan Partners, Forbion and other investors, to advance a second-generation CTLA-4 antibody into earlier-stage cancer treatment.

Solstice secures $225 million to fund neoadjuvant immuno-oncology program

The clinical-stage company is focused on treating cancer in the neoadjuvant setting, before tumors have hardened resistance to therapy. Its lead candidate, porustobart, is a differentiated, Fc-enhanced CTLA-4 antibody being developed across two clinical indications, including microsatellite-stable (MSS) colon cancer and a second, undisclosed indication.

Lemon Seed Sets 2027 Home Service Conference for Lufkin, Texas

Image
Lemon Seed Sets 2027 Home Service Conference for Lufkin, Texas

Lufkin – September 13, 2026 -- Lemon Seed Marketing will host its seventh annual Lemon Seed Conference, themed "Into the Wilderness," on March 3-6, 2027, at Timber Creek Church's Lufkin, Texas campus.

Event combines two days of education with three days of networking for home service leaders

The conference targets home service business owners and leaders, offering sessions on finance and operations, leadership and team building, and community engagement alongside a vendor expo. Crystal Williams, co-owner and lead strategist at Lemon Seed, said the "wilderness" theme reflects how independent home service owners navigate a competitive marketing landscape.

Partillion Bags $2.1M NIH Grant, Tops $8M in Federal Funding

Image
Partillion Bags $2.1M NIH Grant, Tops $8M in Federal Funding

Los Angeles – September 13, 2026 -- Partillion Bioscience has secured a two-year, $2.1 million NIH Small Business Innovation Research (SBIR) award from the National Institute of General Medical Sciences (NIGMS), pushing the company's total non-dilutive federal funding past $8 million.

Tenth SBIR grant matches private capital raised to date

The award, Partillion's 10th SBIR grant, was competitively secured through NIH's Direct-to-Phase II mechanism and roughly matches the company's private investment total, with no additional equity exchanged. The funding, awarded under grant number R44GM165220, will support development of the company's Cell-Cell-seq workflows over two years.

Brennan Breaks Ground on 210,000 SF Nashville Industrial Project

Whites Creek, Tennessee – September 13, 2026 -- Brennan Investment Group has commenced construction on a 210,000 square-foot, Class A speculative industrial facility on 17 acres in Whites Creek, Tennessee, with completion targeted for the second quarter of 2027.

Site sits eight miles from downtown Nashville with direct interstate access

The property is located less than a half-mile from the Interstate 24 interchange at Old Hickory Boulevard, giving future occupiers access to Nashville's three major interstates. Andrew Mazey, Brennan's Senior Vice President for the Nashville and Atlanta regions, said the location will draw last-mile and regional distribution users, and sits a 30-minute drive from Clarksville, Tennessee, a fast-growing manufacturing market.

SuperX Buys Back 119,360 Shares at $7.77 Under $20M Program

Singapore – September 13, 2026 -- SuperX AI Technology Limited (NASDAQ: SUPX) repurchased 119,360 ordinary shares on September 8, 2026, at an average net price of US$7.7691 per share, a transaction valued at roughly US$927,000.

Board authorizes $20 million buyback program through August 2027

SuperX's Board of Directors approved the 2026 Repurchase Program on August 6, 2026, granting management authority to repurchase up to US$20 million of ordinary shares over the following twelve months. The company stated the move reflects Board and management confidence that current market valuation does not fully capture the firm's intrinsic value and long-term growth potential.

Eddid USA Taps tZERO for Digital Asset Securities Custody, Clearing

New York – September 13, 2026 -- Eddid Securities USA Inc., a FINRA-registered introducing broker-dealer, has secured FINRA-approved correspondent clearing arrangements with tZERO Group under FINRA Rule 4311, granting its clients regulated access to digital asset securities trading and custody.

Eddid USA gains access to tZERO Securities ATS for eligible digital asset securities

Eddid USA, the U.S. subsidiary of Hong Kong-based Eddid Financial, has entered agreements with tZERO's regulated broker-dealer subsidiaries covering trading, clearing, and custody. As a subscriber to the tZERO Securities ATS, operated by tZERO Securities, LLC, Eddid USA can now facilitate customer trading in eligible securities, including digital asset securities.

Cardiol Therapeutics to Present at H.C. Wainwright Conference Sept. 14

Image
Cardiol Therapeutics to Present at H.C. Wainwright Conference Sept. 14

Toronto – September 13, 2026 -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) will hold a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference in New York on September 14, 2026, at 10:30 a.m. EDT.

Cardiol schedules investor session at Lotte New York Palace Hotel

The session takes place in the Louis Room on the fourth floor of the venue. A live webcast will be available under the Events & Presentations section of the company's investor website.

Company advances Phase III trial for recurrent pericarditis treatment

Cardiol's lead candidate, CardiolRx, is being evaluated in the pivotal Phase III MAVERIC trial (NCT06708299) for recurrent pericarditis, following the completed Phase II MAvERIC-Pilot study (NCT05494788). The U.S. FDA has granted Orphan Drug Designation to CardiolRx for pericarditis, including the recurrent form of the disease.

Kazia Doses First Patient in Pediatric Brain Cancer Study

Image
Kazia Doses First Patient in Pediatric Brain Cancer Study

Sydney – September 13, 2026 -- Kazia Therapeutics Limited (NASDAQ: KZIA) has dosed the first patient in Arm A of PNOC035, a Phase 2 platform study testing paxalisib combined with gemcitabine for recurrent or progressive atypical teratoid/rhabdoid tumor (AT/RT), an aggressive pediatric brain cancer with no approved therapies.

Preclinical data showed the combination nearly quadrupled median survival in an AT/RT model

In an orthotopic AT/RT preclinical model, the paxalisib-gemcitabine combination extended median survival from 22 to 82.5 days (p0.0001) and showed complementary anti-tumor activity across multiple AT/RT cell lines. These findings, previously presented at ISPNO, AACR and Neuro-Oncology meetings, formed the scientific basis for advancing into the multicenter PNOC035 trial.

BEN, Cataneo Debut AI-Enhanced MYDAS Ad Platform at IBC2026

Image
BEN, Cataneo Debut AI-Enhanced MYDAS Ad Platform at IBC2026

New York – – September 12, 2026 -- Brand Engagement Network, Inc. (NASDAQ: BNAI) and Cataneo GmbH will present an AI-enhanced version of the MYDAS advertising platform at IBC2026, targeting broadcasters and media companies still running on legacy on-premises systems.

MYDAS already processes inventory for more than 1,000 media brands

Cataneo's cloud-native MYDAS platform manages advertising sales, scheduling, traffic, content management, monetization, analytics, CRM integration, and real-time reporting across more than 1,000 media brands and over 200 broadcast and digital channels worldwide, including major U.S. film studios.

DIFC to Host 850 Speakers at First Dubai Future Finance Week

Image
DIFC to Host 850 Speakers at First Dubai Future Finance Week

Dubai – September 12, 2026 -- The Dubai International Financial Centre (DIFC), the largest financial hub in the Middle East, Africa and South Asia region, has confirmed the program for the inaugural Dubai Future Finance Week, running from November 2 to 6, 2026, with more than 850 speakers and over 85 events across 14 stages in the city.

DIFC schedules 12 specialized forums under a single financial-sector platform

The event, themed "Finance Reinvented: Converging Innovation, Strategy and Purpose," is structured around six focus areas: fintech, tokenization, Islamic finance, wealth management, sustainable finance and private capital. Each forum is designed to connect global companies, market operators and regulators around a specific segment of financial-sector transformation.

Owl AI Wins Pentagon DUTCH Award for Thermal Imaging Tech

Rochester, N.Y. – September 13, 2026 -- Owl Autonomous Imaging, Inc. (Owl AI) has been selected for an award supporting the Pentagon-led Delivering Unmatched Thermal Capability–Hastened (DUTCH) initiative, backed by the Office of the Assistant Secretary of War for Critical Technologies and the U.S. Army Combat Capabilities Development Command (DEVCOM) C5ISR Center.

Owl AI will apply uncooled LWIR semiconductor technology to next-generation defense thermal systems

As a fabless semiconductor company, Owl develops technology across the full thermal imaging chain, from focal plane arrays and digital readout electronics to camera cores and complete thermal camera systems. Under the award, the company will focus on developing and demonstrating next-generation uncooled long-wave infrared (LWIR) thermal capabilities.

Galmed Rebrands to Eocene, Ends Yorkville Deal, Regains Nasdaq Compliance

Image
Galmed Rebrands to Eocene, Ends Yorkville Deal, Regains Nasdaq Compliance

Ramat Gan, Israel – September 13, 2026 -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) will rebrand as Eocene Ltd. and begin trading under the ticker EOCN on the Nasdaq Capital Market starting September 10, 2026, after terminating its $20 million standby equity purchase agreement with Yorkville and regaining compliance with Nasdaq's minimum bid price rule.

Company terminates $20 million Yorkville equity facility after raising $7.3 million

Galmed terminated its Standby Equity Purchase Agreement with YA II PN, Ltd. (Yorkville), effective September 8, 2026. The facility had provided up to $20 million in equity financing; the company raised approximately $7.3 million through the issuance of 437,947 ordinary shares before termination.

43North Foundation Targets $5 Billion Buffalo Impact, Names New CEO

Image
43North Foundation Targets $5 Billion Buffalo Impact, Names New CEO

Buffalo – September 13, 2026 -- The 43North Foundation has set a target of converting its $100 million investment into $5 billion in economic impact for Buffalo over the next ten years, backed by a leadership transition that takes effect January 1, 2027.

Colleen E. Heidinger will become CEO, succeeding Sarah Tanbakuchi-Ripa

Heidinger, currently President of 43North and with the organization for more than a decade, was selected following a national search led by the Foundation's Board. Tanbakuchi-Ripa is completing her two-year commitment to the role, and both leaders will remain in their current positions through year-end to ensure a smooth handoff. Bill Maggio, Chairman of the 43North Foundation Board, credited Tanbakuchi-Ripa with building the strategy and Heidinger with the relationships to carry it forward.

German Science Bodies Demand Cross-Ministry Health Prevention Strategy

Berlin – September 13, 2026 -- Four of Germany's leading scientific and health organizations have issued a joint call for a cross-departmental national prevention strategy, warning that roughly 40 percent of new cancer cases remain preventable despite decades of research.

Four organizations unite behind a joint policy statement

The Leopoldina National Academy of Sciences, the German Council of Science and Humanities (Wissenschaftsrat), the German Cancer Research Center (DKFZ) and German Cancer Aid (Deutsche Krebshilfe) presented a shared statement demanding that prevention be embedded across all policy fields -- including education, labor, transport, urban planning, environment and social affairs -- rather than confined to the health ministry alone.

ZDF and SRF Launch Streamium Days, Drawing European Media Leaders to Mainz

Image
ZDF and SRF Launch Streamium Days, Drawing European Media Leaders to Mainz

Mainz – September 13, 2026 -- German broadcaster ZDF and Swiss broadcaster SRF launched a new international leadership forum, the Streamium Days, bringing executives from public and private media companies across Europe together at ZDF's Mainz headquarters on September 7-8, 2026.

ZDF director calls turnout beyond expectations

Dr. Florian Kumb, Director Audience at ZDF, said the event exceeded expectations in every respect, citing the openness of discussions and participants' willingness to share knowledge and experience. He described the media industry as being in the midst of profound change, making cross-border learning and shared responses to digital transformation increasingly urgent.

Adani Airports Raises $1B, Valued at $18B by Global Investors

Image
Adani Airports Raises $1B, Valued at $18B by Global Investors

Ahmedabad, India – September 13, 2026 -- Adani Airport Holdings Limited (AAHL) has signed binding agreements to raise ₹9,825 crore (approximately USD 1 billion) in primary equity from a consortium including Alpha Wave Global, Premji Invest, Temasek and BlackRock managed funds, valuing the airports platform at roughly USD 18 billion pre-money.

Investor consortium to hold 5.54% stake after three funding tranches

Under a Share Subscription Agreement and Shareholders' Agreement, the investors will inject capital in three tranches, with the final installment expected by July 2027. Once complete, the consortium will collectively own approximately 5.54% of AAHL, marking one of the largest primary equity investments by financial institutions in India's airport infrastructure sector.

Tech Mahindra Launches Zero Gravity Architecture to Fix Stalled Telco AI

Image
Tech Mahindra Launches Zero Gravity Architecture to Fix Stalled Telco AI

Pune, India – September 13, 2026 -- Tech Mahindra (NSE: TECHM) has unveiled its Zero Gravity Telco Architecture, a framework targeting the structural barrier preventing communication service providers (CSPs) from scaling AI beyond pilot projects into core operations.

Legacy systems create a 'gravitational pull' that stalls AI rollouts

Tech Mahindra's report identifies this barrier as "Legacy Gravity" -- the accumulated weight of decades-old business rules, definitions, and fragmented data embedded in operator systems. The company states that every AI initiative must first negotiate this accumulated complexity before it can deliver measurable value, and that operators rushing to deploy autonomous AI on fragmented systems face higher costs and slower outcomes.

Ceva, LG Electronics Combine UWB Tech, Land Major US Chipmaker Client

Image
Ceva, LG Electronics Combine UWB Tech, Land Major US Chipmaker Client

Rockville, Md. and Seoul, South Korea – September 13, 2026 -- Ceva, Inc. (NASDAQ: CEVA) and LG Electronics have secured a major U.S. semiconductor company as a customer for a jointly developed Ultra-Wideband (UWB) solution, marking commercial validation for the two-company collaboration announced today.

Ceva's baseband IP pairs with LG's RF technology on TSMC's 22nm process

The partnership combines Ceva-Waves UWB baseband and software with UWB radio frequency technology developed by LG's SoC Center, built on TSMC's 22nm process node. The integrated platform targets semiconductor and OEM developers building automotive, industrial and consumer products, aiming to cut engineering effort and integration risk for companies building UWB-enabled SoCs.

Wand AI Adds Zeroport Hardware Layer to Secure AI Access on Air-Gapped Systems

Palo Alto, Calif. – September 13, 2026 -- Wand AI has integrated Zeroport's hardware-enforced access technology into its Sovereign AI offering, allowing government and critical infrastructure programs to deploy AI agents on air-gapped and segmented systems without creating a network route into them.

Zeroport's Fantom boundary eliminates IP-based access into protected systems

The joint architecture routes agent sessions through a sealed Fantom Core that carries no IP packet and terminates no network session. Only keystrokes and mouse input flow inward, while a display-only pixel stream flows outward, mirroring how a cleared human operator interacts with sensitive systems such as grid, water, defense, and core government estates.

LiveU Launches Hybrid Data Plan Bonding Cellular and Starlink for Broadcast

Image
LiveU Launches Hybrid Data Plan Bonding Cellular and Starlink for Broadcast

Hackensack, N.J. – September 13, 2026 -- LiveU has become a Clarus Integrated Reseller, launching Hybrid Data, the first single managed plan combining cellular bonding and Starlink broadband for broadcast field production teams.

LiveU bundles cellular and Starlink into one invoiced service

Hybrid Data delivers and bills cellular data and Starlink connectivity through a single LiveU plan, replacing the need for separate contracts and support channels. Both connections operate side by side in the same workflow, allowing crews to draw on cellular and satellite bandwidth simultaneously during live transmission.